日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

A practical evaluation of statistical methods for the analysis of patient reported outcomes in an observational pharmaceutical study

对观察性药物研究中患者报告结局分析的统计方法进行实用性评估

期刊:PLoS One
影响因子:
doi:10.1371/journal.pone.0344968
Williams, Lucy R; Marongiu, Andrea; Filippidis, Filippos T; Heinzkill, Marion; van Troostenburg, Anna R; Haubrich, Richard; Ramroth, Heribert
药物研究
发表日期：2026
文献求助 收藏

Effectiveness, safety, and patient-reported outcomes of emtricitabine/tenofovir alafenamide-based regimens for the treatment of HIV-1 infection: Final 24-month results from the prospective German TAFNES cohort study

恩曲他滨/替诺福韦艾拉酚胺方案治疗HIV-1感染的有效性、安全性和患者报告结局：德国TAFNES前瞻性队列研究的最终24个月结果

期刊:Hiv Medicine
影响因子:3.2
doi:10.1111/hiv.13728
Stephan, Christoph; Spinner, Christoph D; Rieke, Ansgar; Christensen, Stefan; Mauss, Stefan; Schreiber, Sandra; Albuquerque, Boris; Heinzkill, Marion; Ramroth, Heribert; Stellbrink, Hans-Jürgen
HIV
炎症/感染
微生物学
发表日期：2025
文献求助 收藏

Combined bictegravir, emtricitabine and tenofovir alafenamide for treating people with HIV: a plain language summary of the BICSTaR study up to 1 year

比克替拉韦、恩曲他滨和替诺福韦艾拉酚胺联合治疗 HIV 感染者：BICSTaR 研究长达 1 年的简明摘要

期刊:Future Microbiology
影响因子:2.4
doi:10.1080/17460913.2024.2391190
Esser, Stefan; Inciarte, Alexy; Levy, Itzchak; D'Arminio Monforte, Antonella; Lambert, John S; van Welzen, Berend; Teruya, Katsuji; Boffito, Marta; Liu, Chun-Eng; Aydın, Ozlem A; Thorpe, David; Heinzkill, Marion; Marongiu, Andrea; Cassidy, Tali; Haubrich, Richard; D'Amato, Lisa; Robineau, Olivier
HIV
炎症/感染
微生物学
发表日期：2024
文献求助 收藏